Furthermore, we observed potent inhibition of EBV-infected B cell outgrowth by CD56bright NKG2A+ NK cells already 18 hours after EBV infection and it increased over time for all B cell subsets investigated (Figure 5). The gene discussed is KLRC1; the disease is Epstein-Barr virus infection.